Taysha Gene Therapies, Inc. TSHA EV / sales
EV / sales at other companies
Other financials
Where this comes from
Calculated from Taysha Gene Therapies, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s ev / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s EV / sales?
- Taysha Gene Therapies, Inc. (TSHA) reported EV / sales of 144× in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s EV / sales changed year-over-year?
- Taysha Gene Therapies, Inc.'s EV / sales increased by 352.4% year-over-year, from 31.8× to 144×.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s EV / sales?
- Over 3 years (2022 to 2025), Taysha Gene Therapies, Inc.'s EV / sales has grown at a 56.4% compound annual growth rate (CAGR), from 33.6× to 128.6×.
- What does EV / sales mean?
- Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.